Literature DB >> 33519805

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.

Alexandra Neaga1, Cristina Bagacean2,3, Adrian Tempescul2,3, Laura Jimbu1, Oana Mesaros1, Cristina Blag4, Ciprian Tomuleasa1,5, Corina Bocsan6, Mihaela Gaman7, Mihnea Zdrenghea1,5.   

Abstract

Acute myeloid leukemia (AML) is an aggressive myeloid malignancy with poor outcomes despite very intensive therapeutic approaches. For the majority of patients which are unfit and treated less intensively, the prognosis is even worse. There has been unspectacular progress in outcome improvement over the last decades and the development of new approaches is of tremendous interest. The tumor microenvironment is credited with an important role in supporting cancer growth, including leukemogenesis. Macrophages are part of the tumor microenvironment and their contribution in this setting is increasingly being deciphered, these cells being credited with a tumor supporting role. Data on macrophage role and polarization in leukemia is scarce. MicroRNAs (miRNAs) have a role in the post-transcriptional regulation of gene expression, by impending translation and promoting degradation of messenger RNAs. They are important modulators of cellular pathways, playing major roles in normal hematopoietic differentiation. miRNA expression is significantly correlated with the prognosis of hematopoietic malignancies, including AML. Oncogenic miRNAs correlate with poor prognosis, while tumor suppressor miRNAs, which inhibit the expression of proto-oncogenes, are correlated with a favorable prognosis. miRNAs are proposed as biomarkers for diagnosis and prognosis and are regarded as therapeutic approaches in many cancers, including AML. miRNAs with epigenetic or modulatory activity, as well as with synergistic activity with chemotherapeutic agents, proved to be promising therapeutic targets in experimental, pre-clinical approaches. The clinical availability of emerging compounds with mimicking or suppressor activity provides the opportunity for future therapeutic targeting of miRNAs. The present paper is focusing on miRNAs which, according to current knowledge, favorably impact on AML outcomes, being regarded as tumor suppressors, and reviews their role in macrophage polarization. We are focusing on miRNA expression in the setting of AML, but data on correlations between miRNA expression and macrophage polarization is mostly coming from studies involving normal tissue.
Copyright © 2021 Neaga, Bagacean, Tempescul, Jimbu, Mesaros, Blag, Tomuleasa, Bocsan, Gaman and Zdrenghea.

Entities:  

Keywords:  acute myeloid leukemia; macrophage polarization; macrophages (M1/M2); non-coding RNAs; tumor suppressor microRNA

Year:  2021        PMID: 33519805      PMCID: PMC7845488          DOI: 10.3389/fimmu.2020.582915

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  124 in total

1.  Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Authors:  Byung-Sik Cho; Zhihong Zeng; Hong Mu; Zhiqiang Wang; Sergej Konoplev; Teresa McQueen; Marina Protopopova; Jorge Cortes; Joseph R Marszalek; Sheng-Bin Peng; Wencai Ma; R Eric Davis; Donald E Thornton; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2015-06-01       Impact factor: 22.113

2.  Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers.

Authors:  Michal Abraham; Yaron Pereg; Baruch Bulvik; Shiri Klein; Inbal Mishalian; Hana Wald; Orly Eizenberg; Katia Beider; Arnon Nagler; Rottem Golan; Abi Vainstein; Arnon Aharon; Eithan Galun; Yoseph Caraco; Reuven Or; Amnon Peled
Journal:  Clin Cancer Res       Date:  2017-08-23       Impact factor: 12.531

3.  miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.

Authors:  Yi Xiao; Changliang Su; Taoran Deng
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

4.  Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.

Authors:  Xiaomeng Huang; Sebastian Schwind; Bo Yu; Ramasamy Santhanam; Hongyan Wang; Pia Hoellerbauer; Alice Mims; Rebecca Klisovic; Alison R Walker; Kenneth K Chan; William Blum; Danilo Perrotti; John C Byrd; Clara D Bloomfield; Michael A Caligiuri; Robert J Lee; Ramiro Garzon; Natarajan Muthusamy; Ly James Lee; Guido Marcucci
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

Review 5.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

6.  Expression of microRNA miR-34a inhibits leukemia stem cells and its metastasis.

Authors:  S Wang; T Wang; M-Z Li; X-L Cheng; X-L Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-07       Impact factor: 3.507

Review 7.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

8.  miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.

Authors:  N Amodio; M T Di Martino; U Foresta; E Leone; M Lionetti; M Leotta; A M Gullà; M R Pitari; F Conforti; M Rossi; V Agosti; M Fulciniti; G Misso; F Morabito; M Ferrarini; A Neri; M Caraglia; N C Munshi; K C Anderson; P Tagliaferri; P Tassone
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

9.  In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.

Authors:  Maria Teresa Di Martino; Virginia Campani; Gabriella Misso; Maria Eugenia Gallo Cantafio; Annamaria Gullà; Umberto Foresta; Pietro Hiram Guzzi; Maria Castellano; Anna Grimaldi; Vincenzo Gigantino; Renato Franco; Sara Lusa; Mario Cannataro; Pierosandro Tagliaferri; Giuseppe De Rosa; Pierfrancesco Tassone; Michele Caraglia
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  A Journey with Elie Metchnikoff: From Innate Cell Mechanisms in Infectious Diseases to Quantum Biology.

Authors:  Fabrice Merien
Journal:  Front Public Health       Date:  2016-06-16
View more
  3 in total

Review 1.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

2.  MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1.

Authors:  Jhen-Hao Jhan; Wei-Chi Hsu; Yi-Chen Lee; Wei-Ming Li; A-Mei Huang; Hui-Hui Lin; Chien-Sheng Wang; Yi-Ru Wu; Ching-Chia Li; Wen-Jeng Wu; Hung-Lung Ke
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

3.  Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.

Authors:  Shantanu Gupta; Ronaldo F Hashimoto
Journal:  Biomolecules       Date:  2022-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.